Yet, while NK cells may play a non-redundant role in controlling MHC-I-null and IFNγ-resistant tumor variants, a higher incidence of such tumors in patients with acquired immunotherapy resistance signifies an escape from NK cell-mediated control. This evidence concerns the gene IFNG and neoplasm.